Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.50
-0.03 (-0.38%)
At close: Mar 28, 2025, 4:00 PM
6.45
-0.05 (-0.77%)
After-hours: Mar 28, 2025, 7:27 PM EDT

Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $628.43 million. The enterprise value is $521.84 million.

Market Cap 628.43M
Enterprise Value 521.84M

Important Dates

The last earnings date was Tuesday, March 18, 2025, after market close.

Earnings Date Mar 18, 2025
Ex-Dividend Date n/a

Share Statistics

TRVI has 96.68 million shares outstanding. The number of shares has increased by 2.97% in one year.

Current Share Class 96.68M
Shares Outstanding 96.68M
Shares Change (YoY) +2.97%
Shares Change (QoQ) +4.67%
Owned by Insiders (%) 1.01%
Owned by Institutions (%) 59.49%
Float 73.67M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.11
P/TBV Ratio 6.31
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.41, with a Debt / Equity ratio of 0.01.

Current Ratio 10.41
Quick Ratio 10.29
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12,881.00

Financial Efficiency

Return on equity (ROE) is -52.59% and return on invested capital (ROIC) is -34.90%.

Return on Equity (ROE) -52.59%
Return on Assets (ROA) -32.15%
Return on Invested Capital (ROIC) -34.90%
Return on Capital Employed (ROCE) -51.32%
Revenue Per Employee n/a
Profits Per Employee -$1.84M
Employee Count 26
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -30,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +87.32% in the last 52 weeks. The beta is 0.91, so TRVI's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change +87.32%
50-Day Moving Average 4.86
200-Day Moving Average 3.55
Relative Strength Index (RSI) 66.37
Average Volume (20 Days) 4,389,232

Short Selling Information

The latest short interest is 4.68 million, so 4.84% of the outstanding shares have been sold short.

Short Interest 4.68M
Short Previous Month 3.79M
Short % of Shares Out 4.84%
Short % of Float 6.35%
Short Ratio (days to cover) 1.11

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -51.52M
Pretax Income -38.78M
Net Income -47.91M
EBITDA -51.38M
EBIT -51.52M
Earnings Per Share (EPS) -$0.47
Full Income Statement

Balance Sheet

The company has $107.62 million in cash and $1.03 million in debt, giving a net cash position of $106.59 million or $1.10 per share.

Cash & Cash Equivalents 107.62M
Total Debt 1.03M
Net Cash 106.59M
Net Cash Per Share $1.10
Equity (Book Value) 99.64M
Book Value Per Share 1.06
Working Capital 98.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.26 million and capital expenditures -$35,000, giving a free cash flow of -$38.29 million.

Operating Cash Flow -38.26M
Capital Expenditures -35,000
Free Cash Flow -38.29M
FCF Per Share -$0.40
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.97%
Shareholder Yield n/a
Earnings Yield -7.62%
FCF Yield -6.09%

Analyst Forecast

The average price target for TRVI is $17.56, which is 170.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.56
Price Target Difference 170.15%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1